Quantitative HIV-1 proviral DNA detection: A multicentre analysis

New Microbiologica

Volumn 33, Issue 4, 2010, Pages 293-302

  De Rossi, Anita ^a   Zanchetta, Marisa ^a   Vitone, Francesca ^b   Antonelli, Guido ^c   Bagnarelli, Patrizia ^d   Buonaguro, Luigi ^e   Capobianchi, Maria Rosaria ^f   Clementi, Massimo ^g   Abbate, Isabella ^f   Canducci, Filippo ^g   Monachetti, Alessia ^d   Riva, Eisabetta ^h   Rozera, Gabriella ^f   Scagnolari, Carolina ^c   Tagliamonte, Maria ^e   Re, Maria Carla ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Dna detection; HIV; Standardization

Indexed keywords

GAG PROTEIN; TELOMERASE; TERT PROTEIN, HUMAN; VIRUS DNA;

ARTICLE; CELL LINE; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; ITALY; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PROVIRUS; SENSITIVITY AND SPECIFICITY; STANDARD; VIROLOGY; VIRUS LOAD;

CELL LINE; DNA, VIRAL; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; ITALY; POLYMERASE CHAIN REACTION; PROVIRUSES; SENSITIVITY AND SPECIFICITY; TELOMERASE; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650230470     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. BELOUKAS A., PARASKEVIS D., PSICHOGIOU M., HATZAKIS A. (2009a). The role of HIV-1 DNA as an additional marker of HIV-1 infection. Curr. HIV Res. 7, 255-265.
2. BELOUKAS A., PARASKEVIS D., HAIDA C., SYPSA V., HATZAKIS A. (2009b). Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA. J. Clin. Microbiol. 47, 2194-2199.
3. BRUSELLES A., ROZERA G., BARTOLINI B., PROSPERI M., DEL NONNO F., NARCISO P., CAPOBIANCHI M.R., ABBATE I. (2009). Use of massive parallel pyrosequencing for near full-length characterization of a unique HTV Type 1 BF recombinant associated with a fatal primary infection. AIDS Res. Hum. Retroviruses. 25, 937-942.
4. BUONAGURO L., PETRIZZO A., TAGLIAMONTE M., VITONE F., RE M.C., PILOTTI E. CASOLI C., SBREGLIA C., PERRELLA O., TORNESELLO M.L., BUONAGURO F.M. (2008). Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. Infect. Agent. Cancer. 3, 13-18.
5. BUONAGURO L., TAGLIAMONTE M., TORNESELLO M., BUONAGURO F.M. (2007a). Evolution of the HIV-1 V3 region in the Italian epidemic. New Microbiol. 30, 1-11.
6. BUONAGURO L., TAGLIAMONTE M., TORNESELLO M.L., BUONAGURO F.M. (2007b). Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example. Retrovirology. 21, 4, 34-40.
7. BUTLER S.L., JOHNSON E.P., BUTLER S.L., JOHNSON E.P., BUSHMAN F.D. (2002). Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J. Virol. 76, 3739-3747.
8. CARA A., VARGAS J. JR, KELLER M., JONES S., MOSOIAN A., GURTMAN A., COHEN A., PARKAS V., WALLACH F., CHUSID E., GELMAN I.H., KLOTMAN M.E. (2002). Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA. Virol. 292, 1-5.
9. Clementi M. Quantitative molecular analysis of virus expression and replication Journal of Clinical Microbiology 2000 38 6 2030-2036 CLEMENTI M. (2000). Quantitative analysis of virus expression and replication. J. Clin. Microbiol. 38, 2030-2036. (Pubitemid 30414311)
10. DE ROSSI A., MASIERO S., GIAQUINTO C., RUGA E., COMAR M., GIACCA M., CHIECO-BIANCHI L. (1996). Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J. Clin. Invest. 97, 323-323.
11. Desire N. Dehee A. Schneider V. Jacomet C. Goujon C. Girard P.-M. Rozenbaum W. Nicolas J.-C. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay Journal of Clinical Microbiology 2001 39 4 1303-1310 DOI 10.1128/JCM.39.4.1303-1310.2001 DÉSIRÉ N., DEHÉE A., SCHNEIDER V., JACOMET C., GOUJON C., GIRARD P.M., ROZENBAUM W., NICOLAS J.C. (2001). Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol. 39, 1303-1310. (Pubitemid 32275425)
12. D'ETTORRE G., ZAFFIRI L., CECCARELLI G., MASTROIANNI C.M., VULLO V (2010). The role of HIV-DNA testing in clinical practice. New Microbiol. 33, 1-11.
13. FOLEY G.E., LAZARUS H., FARBER S., UZMAN B.G., BOONE B.A., MCCARTHY R.E. (1965). Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 18, 522-529.
14. FOLKS T.M., POWELL D., LIGHTFOOTE M., KOENIG S., FAUCI A.S., BENN S., RABSON A., DAUGHERTY D., GENDELMAN H.E., HOGGAN M.D. (1986). Biological and biochemical characterization of a cloned Leu3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J. Exp. Med. 164, 280-290.
15. GALLI M., BALOTTA C., MERONI L., COLOMBO M.C., PAPAGNO L., BAGNARELLI P., TESTA L., VARCHETTA S., COLOMBO L., MORONI M., D'ARMINIO MONFORTE A., CLERICI M., CLEMENTI M. (1998). Early increase in cell-associated HPvM DNA in patients on highly active antiretroviral therapy. AIDS. 12, 2500-2502.
16. GARBUGLIA A.R., CALCATERRA. S., D'OFFIZI G., TOPINO S., NARCISO P., LILLO F., GIRARDI E., CAPOBIANCHI M.R. (2004). HIV-1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption. J. Med. Virol. 74, 373-381.
17. GIBELLINI D., BORDERI M., DE CRIGNIS E., CICOLA R., CIMATTI L., VITONE F., CHIODO F., RE M.C. (2008). HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naive and HAARTtreated individuals. J. Infect. 56, 219-225.
18. GIBELLINI D., VITONE F., BUZZI M., SCHIAVONE P., DE CRIGNIS E., CICOLA R., CONTE R., PONTI C., RE M.C. (2007). HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction. J. Cell. Physiol. 210, 315-324.
19. HATZAKIS A.E., TOULOUMI G., PANTAZIS N., ANASTASSOPOULOU C.G., KATSAROU O., KARAFOULIDOU A., GOEDERT J.J., KOSTRIKIS L.G. (2004). Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy. AIDS. 18, 2261-2267.
20. HIERHOLZER J.C., KILLINGTON R.A. (1996). Virus isolation and quantitation. In: Mahy, B.W.J, and Kangro, H.O. Editors. Virology methods manual. Academic Press, London; 25-46.
21. KABAMBA-MUKADI B., HENRIVAUX P., RUELLE J., DELFERRIÈRE N., BODÉlUS M., GOUBAU P. (2005). Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR. BMC Infect. Dis. 21; 15.
22. KATZENSTEIN T.L., OLTVERI R.S., BENFIELD T., EUGENOLSEN J., NIELSEN C., GERSTOFT J. (2002). Cell-associated HIV DNA measured early during infection has prognostic value independent of serum HIV RNA measured concomitantly. Scand. J. Infect. Dis. 34, 529-533.
23. KOSTRIKIS L.G., TOULOUMI G., KARANICOLAS R., PANTAZIS N., ANASTASSOPOULOU C., KARAFOULIDOU A., GOEDERT J.J., HATZAKIS A., MULTICENTER HEMOPHILIA COHORT STUDY GROUP. (2002). Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J. Virol. 76, 10099-10108.
24. KULKOSKY J., BRAY S. (2006). HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication. Curr. HIV Res. 4, 199-208.
25. LILLO F.B., GRASSO M.A., LODINI S., BELLOTTI M.G., COLUCCI G. (2004). Few modifications of the Cobas Amplicor HTV Monitor 1.5 test allow reliable quantitation of HIV-1 proviral load in peripheral blood mononuclear cells. 7. Virol. Methods. 120, 201-205.
26. NGO-GIANG-HUONG N., DEVEAU C., DA SILVA I., PELLEGRIN I., VENET A., HARZIC M., SINET M., DELFRAISSY J.F., MEYER L., GOUJARD C., ROUZIOUX C., FRNECH PRIMO COHORT STUDY GROUP. (2001) Proviral HIV-1 DNA in subjects followed since primary HTV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy. AIDS. 15, 665-673.
27. NOË A., PLUM J., VERHOFSTEDE C. (2005). The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance. J. Antimicrob. Chemother. 55, 410-412.
28. Ometto L. De Forni D. Patiri F. Trouplin V. Mammano F. Giacomet V. Giaquinto C. Douek D. Koup R. De Rossi A. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: Role of thymic output and viral fitness AIDS 2002 16 6 839-849 DOI 10.1097/00002030-200204120-00003 OMETTO L., DE FORNI D., PATIRI F., TROUPLIN V., MAMMANO F., GIACOMET V. GIAQUINTO C., DOUEK D., KOUP R., DE ROSSI A. (2002). Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS. 16, 839-849. (Pubitemid 34409007)
29. PALMISANO L., GIULIANO M., CHIAROTTI E, ZANCHETTA M., ANDREOTTI M., PIRILLO M.F., RTVA E., ANTONELLI G., DE ROSSI A., VELLA S. (2008). Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 48, 68-71.
30. PARASKEVIS D., PYBUS O., MAGIORKINIS G., HATZAKIS A., WENSING A.M., VAN DE VIJVER D.A., ALBERT J., ANGARANO G., ASJÖ B., BALOTTA C., BOERI E., CAMACHO R., CHALX M.L., COUGHLAN S., COSTAGLIOLA D., DE LUCA A., DE MENDOZA C., DERDELINCKX I., GROSSMAN Z., HAMOUDA O., HOEPELMAN I., HORBAN A., KORN K., KÜCHERER C., LEITNER T., LOVEDAY C., MACRAE E., MALJKOVIC-BERRY I., MEYER NIELSEN C., OP DE COUL E.L., ORMAASEN V., PERRIN L., PUCHHAMMER-STÖCKL E., RUIZ L., SALMINEN M.O., SCHMIT J.C., SCHUURMAN R., SORIANO V., STANCZAK J., STANOJEVIC M., STRUCK D., VAN LAETHEM K., VIOLIN M., YERLY S., ZAZZI M., BOUCHER C.A., VANDAMME A.M.; SPREAD PROGRAMME. (2009). Tracing the HTV-I subtype B mobility in Europe: a phylogeographic approach. Retrovirology. 6, 49.
31. Perelson A.S. Essunger P. Cao Y. Vesanen M. Hurley A. Saksela K. Markowitz M. Ho D.D. Decay characteristics of HIV-1-infected compartments during combination therapy Nature 1997 387 6629 188-191 DOI 10.1038/387188a0 PERELSON A.S., ESSUNGER P., CAO Y., VESANEN M., HURLEY A., SAKSELA K., MARKOWITZ M., HO D.D. (1997), Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 387, 188-191. (Pubitemid 27209434)
32. RAMRATNAM B., MITTLER J.E., ZHANG L., BODEN D., HURLEY A., FANG F., MACKEN C.A., PERELSON A.S., MARKOWITZ M., HO D.D. (2000). The decay of the latent reservoir of replication-competent HTV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat. Med. 6, 82-85.
33. RE M.C., VITONE F., BIAGETTI C., SCHIAVONE P., ALESSANDRINI F., BON I., DE CRIGNIS E., GIBELLINI D. (2009). HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. Clin. Microbiol. Infect. Sep 2.11.
34. RE M.C., VITONE F., BON I., SCHIAVONE P.GIBELLINI D. (2006). Meaning of DNA detection during the follow-up of HIV-1infected patients: a brief review. New Microbiol. 29, 81-88.
35. RE M.C., VITONE F., SIGHINOLFI L., SCHIAVONE P., GHINELLI F., GIBELLINI D. (2005). Different patterns of HPZ-I DNA after therapy discontinuation. BMC Infect. Dis. 5, 69-75.
36. ROUZIOUX C., HUBERT J.B., BURGARD M., DEVEAU C., GOUJARD C., BARY M., SERENÍ D., VIARD J.P., DELFRAISSY J.F., MEYER L. (2005). Early levels of HTV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-I RNA levels and CD4+ T cell counts. J. Infect. Dis. 192, 46-55.
37. ROZERA G., ABBATE I., BRUSELLES A., BARTOLINI B., D'OFFIZI G., NICASTRI E., TOMMASI C., CAPOBIANCHI M.R. (2010). Comparison of real-time PCR methods for measurement of HIV-1 proviral DNA. J. Virol. Methods. 164, 35-38.
38. SARMATI L., PARISI S.G., NICASTRI E., D'ETTORRE G., PALMISANO L., ANDREOTTI M., ANDREONI C., GIULIANO M., GATTI F., BOLDRIN C., PALÙ G., VULLO V., VELLA S., ANDREONI M. (2005). Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy. J. Clin. Microbiol. 43, 6183-6185.
39. SHARKEY M.E., TEO I., GREENOUGH T., SHAROVA N., LUZURIAGA K., SULLIVAN J.L., BUCY R.P., KOSTRKIS L.G., HAASE A., VERYARD C., DAVARO R.E., CHEESEMAN S.H., DALY J.S., BOVA C., ELLISON R.T. 3RD, MADY B., LAI K.K., MOYLE G., NELSON M., GAZZARD B., SHAUNAK S., STEVENSON M. (2000) Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat. Med. 6, 76-81.
40. Sozzi G. Conte D. Leon M. Cirincione R. Roz L. Ratcliffe C. Roz E. Cirenei N. Bellomi M. Pelosi G. Pierotti M.A. Pastorino U. Quantification of free circulating DNA as a diagnostic marker in lung cancer Journal of Clinical Oncology 2003 21 21 3902-3908 DOI 10.1200/JCO.2003.02.006 SOZZI G., CONTE D., LEON M., CIRICIONE R., ROZ L., RATCLIFFE C., ROZ E., CIRENEI N., BELLOMI M., PELOSI G., PIEROTTI M.A., PASTORINO U. (2003). Quantification of free circulating DNA as a diagnostic marker in lung cancer. J. Clin. Oncol. 21, 3902-3908. (Pubitemid 46606202)
41. TAGLIAMONTE M., VIDAL N., TORNESELLO M.L., PEETERS M., BUONAGURO F.M., BUONAGURO L. (2006). Genetic and phylogenetic characterization of structural genes from non-B HIV-1 subtypes in Italy. AIDS Res. Hum. Retroviruses. 22, 1045-1051.
42. VITONE F., GIBELLINI D., SCHIAVONE P., RE M.C. (2005). Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. J. Clin. Virol. 33, 194-200.
43. Zanchetta M. Walker S. Burighel N. Bellanova D. Rampon O. Giaquinto C. De Rossi A. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy Journal of Infectious Diseases 2006 193 12 1718-1727 DOI 10.1086/504264 ZANCHETTA M., WALKER S., BURIGHEL N., BELLANOVA D., RAMPON O., GIAQUINTO C., DE ROSSI A. (2006). Longterm decay of the HIV-1 reservoir in HPV-1-infected children treated with highly active antiretroviral therapy. J. Infect. Dis. 193, 1718-1727. (Pubitemid 43839477)